Scleroderma/Systemic Sclerosis (2013 EULAR/ACR Criteria)

Review EULAR/ACR criteria for scleroderma

The global unit selector only affects unanswered questions
1.These criteria are not applicable to a) patients having a SSc-like disorder better explaining their manifestations (below) or b) patients with skin thickening sparing the fingers
2.Skin Changes?
3.Finger Tip Lesions?
4.Telangiectasias?
5.Abnormal Nailfold Capillaries?
6.Pulmonary Arterial Hypertension and/or Interstitial lung Disease?
7.Raynaud's Phenomenon?
8.Scleroderma Related Antibodies?
Created by

1. These criteria are not applicable to a) patients having a SSc-like disorder better explaining their manifestations (below) or b) patients with skin thickening sparing the fingers

More Information

SSc-like disorders: nephrogenic sclerosing fibrosis, generalized morphea, eosinophilic fasciitis, scleredema diabeticorum, scleromyxedema, erythromyalgia, porphyria, lichen sclerosis, graft versus host disease, and diabetic cheiropathy.

Created by
0/8 completed

About this Calculator

The European League Against Rheumatism and the American College of Rheumatology (ACR/EULAR) classification criteria were published in 2013. It was determined that skin thickening of the fingers extending proximal to the metacarpophalangeal joints is sufficient for to classify a patient as systemic sclerosis.

In the absence of this finding, seven findings should be identified and score: skin thickening of the fingers, fingertip lesions, telangiectasia, abnormal nailfold capillaries, interstitial lung disease or pulmonary arterial hypertension, Raynaud's phenomenon, and SSc-related autoantibodies.

Patients with a score ≥9 are considered to have definite systemic sclerosis (scleroderma). Sensitivity was 91% and specificity was 92% in the validation sample for the new classification criteria. This is far superior to the 75% and 72% for the 1980 ACR classification criteria.

Legal Notices and Disclaimer

© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.